SG11202104276YA - Peptide fragments for treatment of diabetes - Google Patents
Peptide fragments for treatment of diabetesInfo
- Publication number
- SG11202104276YA SG11202104276YA SG11202104276YA SG11202104276YA SG11202104276YA SG 11202104276Y A SG11202104276Y A SG 11202104276YA SG 11202104276Y A SG11202104276Y A SG 11202104276YA SG 11202104276Y A SG11202104276Y A SG 11202104276YA SG 11202104276Y A SG11202104276Y A SG 11202104276YA
- Authority
- SG
- Singapore
- Prior art keywords
- diabetes
- treatment
- peptide fragments
- fragments
- peptide
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18204862 | 2018-11-07 | ||
| PCT/EP2019/080563 WO2020094797A1 (en) | 2018-11-07 | 2019-11-07 | Peptide fragments for treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104276YA true SG11202104276YA (en) | 2021-05-28 |
Family
ID=64183928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104276YA SG11202104276YA (en) | 2018-11-07 | 2019-11-07 | Peptide fragments for treatment of diabetes |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20220002343A1 (https=) |
| EP (1) | EP3876970A1 (https=) |
| JP (1) | JP7553115B2 (https=) |
| KR (1) | KR20210088583A (https=) |
| CN (1) | CN113164548A (https=) |
| AU (1) | AU2019374981A1 (https=) |
| BR (1) | BR112021008888A2 (https=) |
| CA (1) | CA3116612A1 (https=) |
| IL (1) | IL282519A (https=) |
| MX (1) | MX2021005386A (https=) |
| SG (1) | SG11202104276YA (https=) |
| WO (1) | WO2020094797A1 (https=) |
| ZA (1) | ZA202102572B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023218095A1 (en) * | 2022-05-13 | 2023-11-16 | Coegin Pharma Ab | Agents for stimulating tissue regeneration |
| JP2025516717A (ja) * | 2022-05-13 | 2025-05-30 | コーギン ファーマ エービー | 血管新生を誘発する薬剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10505750A (ja) * | 1994-09-16 | 1998-06-09 | ザ スクリップス リサーチ インスティテュート | 粘着および軸索の成長を刺激するサイトタクチン誘導体並びにその製造および使用方法 |
| WO2004015390A2 (en) | 2002-08-09 | 2004-02-19 | Applera Corporation | Lung cancer target proteins and use thereof |
| CN100503637C (zh) * | 2004-04-14 | 2009-06-24 | 浙江贝达药业有限公司 | 胰高血糖素样肽类似物、其组合物及其使用方法 |
| US9044438B2 (en) * | 2005-06-17 | 2015-06-02 | Yitzchak Hillman | Disease treatment via antimicrobial peptides or their inhibitors |
| EP2114422A1 (en) * | 2007-03-02 | 2009-11-11 | National University of Ireland, Galway | Osteopontin for the prediction and treatment of cardiovascular diseases |
| GB2493540A (en) * | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
| GB201406989D0 (en) * | 2014-04-17 | 2014-06-04 | Follicum Ab | Novel treatments |
| CA3061935A1 (en) * | 2017-05-04 | 2018-11-08 | Follicum Ab | Peptides for treatment of diabetes |
-
2019
- 2019-11-07 US US17/289,408 patent/US20220002343A1/en not_active Abandoned
- 2019-11-07 MX MX2021005386A patent/MX2021005386A/es unknown
- 2019-11-07 JP JP2021524174A patent/JP7553115B2/ja active Active
- 2019-11-07 EP EP19812678.1A patent/EP3876970A1/en active Pending
- 2019-11-07 BR BR112021008888-1A patent/BR112021008888A2/pt not_active Application Discontinuation
- 2019-11-07 CA CA3116612A patent/CA3116612A1/en active Pending
- 2019-11-07 SG SG11202104276YA patent/SG11202104276YA/en unknown
- 2019-11-07 CN CN201980081421.2A patent/CN113164548A/zh active Pending
- 2019-11-07 AU AU2019374981A patent/AU2019374981A1/en not_active Abandoned
- 2019-11-07 KR KR1020217014389A patent/KR20210088583A/ko not_active Ceased
- 2019-11-07 WO PCT/EP2019/080563 patent/WO2020094797A1/en not_active Ceased
-
2021
- 2021-04-19 ZA ZA2021/02572A patent/ZA202102572B/en unknown
- 2021-04-21 IL IL282519A patent/IL282519A/en unknown
-
2024
- 2024-06-17 US US18/744,868 patent/US20240327459A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019374981A1 (en) | 2021-05-27 |
| BR112021008888A2 (pt) | 2021-08-17 |
| KR20210088583A (ko) | 2021-07-14 |
| ZA202102572B (en) | 2022-10-26 |
| US20240327459A1 (en) | 2024-10-03 |
| CA3116612A1 (en) | 2020-05-14 |
| IL282519A (en) | 2021-06-30 |
| US20220002343A1 (en) | 2022-01-06 |
| WO2020094797A1 (en) | 2020-05-14 |
| JP2022516400A (ja) | 2022-02-28 |
| EP3876970A1 (en) | 2021-09-15 |
| MX2021005386A (es) | 2021-07-06 |
| JP7553115B2 (ja) | 2024-09-18 |
| CN113164548A (zh) | 2021-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202104923YA (en) | Pharmaceutical combination for treatment of cancer | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| ZA201905851B (en) | Peptides and methods for the treatment of diabetes | |
| IL270199A (en) | Peptides for the treatment of diabetes | |
| EP3256158A4 (en) | Tolerance therapeutic for treating polypeptide induced allergy | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| GB201707207D0 (en) | Treatment of type 1 diabetes | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL282519A (en) | Peptide fragments for the treatment of diabetes | |
| GB201916428D0 (en) | Treatment of hydro-carbon-contaminated materials | |
| PT3833378T (pt) | Tratamento de verrugas | |
| IL284029A (en) | Peptides for the treatment and prevention of diabetes and related disorders | |
| IL263564B (en) | Peptides for the treatment of osteoarthritis | |
| EP3628048A4 (en) | PEPTIDES FOR CANCER TREATMENT | |
| IL250666A0 (en) | A peptide for the treatment of diabetes mellitus type 2 and its complications | |
| HK40058402A (en) | Peptide fragments for treatment of diabetes | |
| IL282952A (en) | A method for improving peptide kinetics in them | |
| SG11202102683XA (en) | Treatment for obesity | |
| GB201915003D0 (en) | Treatment of hepatotoxicity | |
| HK40068631A (en) | Treatment of diabetes | |
| GB201700849D0 (en) | Citrullinated peptides for diagnosis or treatment of diabetes | |
| GB201805099D0 (en) | Treatment of osteoporotic diseases | |
| HK40018947A (en) | Peptides and methods for the treatment of diabetes | |
| GB201904282D0 (en) | Treatment of osteoporotic diseases | |
| GB201907839D0 (en) | Treatment of hepatotoxicity |